CGTRUACCESS
LIVE

Serial Number

99774517

Owner

CG Oncology Inc.

Attorney

Muzamil Huq

Filing Date

Apr 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CGTRUACCESS Trademark

Serial Number: 99774517

CGTRUACCESS is a trademark filed by CG Oncology Inc. on April 20, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CG Oncology Inc.

3000 Pegasus Park Dr
Dallas, TX 75247

Entity Type: 03

Trademark Details

Filing Date

April 20, 2026

Registration Date

Not Registered

Goods & Services

Business assistance services in the field of pharmaceuticals, namely, providing patient access support services; administration of patient support programs; providing reimbursement support services, namely, insurance benefits verification, prior authorization assistance, and claims appeals assistance; administration of financial assistance and co-pay support programs for patients; coordination of patient access to pharmaceutical therapies for patients, healthcare providers, and healthcare provider staff; providing business information and assistance to patients and healthcare providers regarding access to pharmaceutical products; operation of patient access hubs for facilitating access to pharmaceutical treatments; insurance eligibility verification services; patient engagement services for business purposes, namely, providing administrative support in the nature of patient education about program eligibility and access processes, and communication and navigation assistance for patients and caregivers; business management services, namely, care coordination in the nature of arranging scheduling and transportation logistics for patients; providing real-time payer access information for business purposes; field reimbursement support services, namely, assisting healthcare providers with insurance reimbursement processes.

Providing healthcare information in the field of pharmaceuticals and treatment access; patient support services, namely, providing healthcare information and patient advocacy services to assist patients in obtaining access to pharmaceutical treatments; providing patient case management services, namely, coordinating healthcare services for patients in connection with access to pharmaceutical therapies; providing patient care navigation and coordination services, namely, coordinating medical and healthcare services; providing personalized patient education and counseling to improve treatment access and adherence; providing patient advocacy services to address barriers to healthcare access, including providing information and assistance relating to logistical and administrative aspects of obtaining medical treatment; all of the foregoing delivered through human-led and digital engagement models.

Providing temporary use of non-downloadable software for patient support program administration, patient engagement, and communication; providing online portals for patients, caregivers, and healthcare providers for accessing information, exchanging documentation, and managing access to pharmaceutical therapies; providing temporary use of non-downloadable software for data analytics, reporting, and dashboards relating to patient access, reimbursement, and treatment initiation; providing temporary use of non-downloadable software utilizing artificial intelligence for predicting patient access barriers, optimizing workflows, and automating patient support services; providing temporary use of non-downloadable software for integration with electronic health records and healthcare provider systems.

Financial assistance services, namely, providing financial assistance to patients for the purchase of pharmaceutical products; administration of co-payment assistance, patient assistance, and reimbursement programs

Downloadable software featuring online portals for patients, caregivers, healthcare providers, and healthcare provider staff for accessing information, tracking status, exchanging documentation, and managing access to pharmaceutical therapies; downloadable software for administration of patient support programs and for reporting and analytics related to treatment access; downloadable software featuring patient engagement applications, digital companion applications, and communication platforms for use by patients, caregivers, and healthcare providers; downloadable software utilizing artificial intelligence and data analytics for managing patient access, treatment coordination, and reimbursement workflows.

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 20, 2026 MAFR
NEW APPLICATION ENTERED
Apr 20, 2026 NWAP